Dalton, Greiner, Hartman, Maher & Co’s Harvard Bioscience HBIO Stock Holding History

Dalton, Greiner, Hartman, Maher & Co’s Portfolio HBIO Stock Details HBIO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell
2021 Q1	$489K	Sell
2020 Q4	$1.03M	Sell
2020 Q3	$2.74M	Sell
2020 Q2	$5.14M	Buy
2020 Q1	$3.58M	Buy
2019 Q4	$4.8M	Buy
2019 Q3	$4.22M	Buy
2019 Q2	$2.31M	Buy
2019 Q1	$381K	Buy